KDM6B and acute myeloid leukemia: Although the abovementioned studies focus on KMD6B as a potential oncogene in disease initiation and progression of myeloid malignancy, Yu et al. found a significant role of KDM6B in the differentiation of AML FAB subtypes M2 and M3.